The record
Written by software from the 1 report below. The points restate them; where one says why it matters, that is Prism's reading, not a reported fact.
- Research published in the journal Diabetes Care highlights that prices for several modern diabetes medications have dropped significantly in India following patent expirations.
- This decline is attributed to a combination of domestic manufacturing, government price regulations, and increased competition among generic drug makers.
- Public healthcare initiatives have further supported patient access to these treatments.
- Maintaining affordable long-term access remains a critical public health goal as diabetes continues to affect a large portion of the global population.
What to watch next
- Ensuring distribution of medicines in rural and underserved areas
- Monitoring quality control and consistency among multiple generic manufacturers
Who said what1
Only words found exactly in the article are shown, attributed and linked to the line they came from.
V. Mohan
chairman, MDRF
1 quote · 1 outlet
“Modern diabetes medicines, which were once considered unaffordable for large sections of society, can become much more accessible through the right combination of government policy, pharmaceutical manufacturing and competition,”
In the article
…them are in low- and middle-income countries,'' according to figures cited in the paper. As newer therapies become available, ensuring that they reach patients at affordable prices is becoming an increasing challenge. “ Modern diabetes medicines, which were once considered unaffordable for large sections of society, can become much more accessible through the right combination of government policy, pharmaceutical manufacturing and competition, ” said Dr V. Mohan, chairman, MDRF and one of the authors of the study. The researchers point to India's pharmaceutical manufacturing base and the availability of multiple generic manufacturers as important factors…
Coverage1
All filed from India
Named India · American Diabetes Association · Ayushman Bharat · Jan Aushadhi Scheme · Madras Diabetes Research Foundation · V Mohan
The 1 report is listed beside the record.
Something wrong?
Say what, and it arrives with this record's address filled in. A correction is welcome.
Ask this story
Answers cite the reports above, or say they can't.
